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Summary
Background: It is proposed that helminth exposure protects against allergy‐related
disease, by mechanisms that include disconnecting risk factors (such as atopy) from
effector responses.
Objective: We aimed to assess how helminth exposure influences rural‐urban differ-
ences in risk factors for allergy‐related outcomes in tropical low‐ and middle‐income
countries.
Methods: In cross‐sectional surveys in Ugandan rural Schistosoma mansoni (Sm)‐
endemic islands, and in nearby mainland urban communities with lower helminth
exposure, we assessed risk factors for atopy (allergen‐specific skin prick test [SPT]
reactivity and IgE [asIgE] sensitization) and clinical allergy‐related outcomes (wheeze,
urticaria, rhinitis and visible flexural dermatitis), and effect modification by Sm
exposure.
Results: Dermatitis and SPT reactivity were more prevalent among urban partici-
pants, urticaria and asIgE sensitization among rural participants. Pairwise associations
between clinical outcomes, and between atopy and clinical outcomes, were stronger
in the urban survey. In the rural survey, SPT positivity was inversely associated with
bathing in lakewater, Schistosoma-specific IgG4 and Sm infection. In the urban sur-
vey, SPT positivity was positively associated with age, non‐Ugandan maternal tribe,
being born in a city/town, BCG scar and light Sm infection. Setting (rural vs urban)
was an effect modifier for risk factors including Sm- and Schistosoma-specific IgG4.
In both surveys, the dominant risk factors for asIgE sensitization were Schistosoma‐
specific antibody levels and helminth infections. Handwashing and recent malaria
treatment reduced odds of asIgE sensitization among rural but not urban partici-
pants. Risk factors for clinical outcomes also differed by setting. Despite suggestive
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trends, we did not find sufficient evidence to conclude that helminth (Sm) exposure
explained rural‐urban differences in risk factors.
Conclusions and clinical relevance: Risk factors for allergy‐related outcomes differ
between rural and urban communities in Uganda but helminth exposure is unlikely
to be the sole mechanism of the observed effect modification between the two set-
tings. Other environmental exposures may contribute significantly.
K E YWORD S
allergy, effect modification, helminths, risk factors, Uganda, urban-rural
1 | INTRODUCTION
Advances in health and hygiene practices have transformed high‐
income countries into “cleaner” environments, with reduced infection
exposure. Consequently, homeostatic immunomodulatory effects of
exposure to microbes and parasites that co‐evolved with mammalian
species (the “old friends hypothesis”) have been lost.1 The surge in
allergy‐related diseases alongside other chronic inflammatory dis-
eases in high‐income countries over recent decades has been partly
attributed to this phenomenon.2 Although other environmental expo-
sures3 may contribute, substantial support for the “old friends
hypothesis” comes from studies in high‐income countries,4-9 which
show that traditional farming and related microbial exposures10 are
associated with protection against allergy‐related diseases. Additional
evidence suggests a parallel relationship between ongoing urbaniza-
tion and increasing allergy‐related disease prevalence in tropical low‐
and middle‐income countries (LMICs).11,12
Akin to farming environments in high‐income countries, rural
LMIC settings are relatively protected against allergy‐related dis-
eases.13-17 Animal models and in vitro experiments in human sam-
ples have identified helminths as potent inhibitors of allergic
reactions,18-20 leading to the hypothesis that they are partly respon-
sible for the low overall prevalence of allergy‐related diseases in
tropical LMICs and the observed rural‐urban disparities in allergy‐
related disease prevalence in the same settings.16,21 Helminths may
dissociate risk factors, such as atopy, from allergy‐related disease:
work in Ugandan children showing that hookworm infection dissoci-
ates allergen‐specific IgE from the effector phase of the allergic
response22 is strongly suggestive. However, little comparative analy-
sis of risk factors for allergy in rural vs urban LMIC settings has been
conducted. Exploration of these factors in LMICs, where an epidemi-
ological transition is ongoing, provides an unprecedented opportunity
to better understand interactions between the environment and the
allergic pathway and allergy‐related disease outcomes.
Using data generated from two surveys in Uganda, one in rural
helminth‐endemic Lake Victoria island fishing villages and another in
nearby mainland urban communities with lower helminth exposure,
we investigated socio‐demographic, behavioural, clinical and
immunological characteristics as risk factors for allergy‐related out-
comes and assessed whether helminth infections contribute to rural‐
urban differences in these risk factors.
2 | METHODS
2.1 | Study settings and procedures
Rural participants were residents of 26 helminth‐endemic fishing vil-
lages of Koome islands, Mukono district, Uganda (population 18 778
in 201423). Urban participants were residents of Entebbe Municipal-
ity, a lower helminth exposure area situated on the northern shores
of Lake Victoria, 40 km southwest of the Ugandan capital, Kampala,
and 35 km from Koome. The municipality had approximately 69 430
inhabitants in 2014,23 distributed across 24 sub‐wards, the smallest
administrative units.
The “rural survey” was part of the Lake Victoria Island Interven-
tion Study on Worms and Allergy‐related diseases (LaVIISWA;
ISRCTN47196031), a cluster‐randomized trial of standard vs inten-
sive anthelminthic intervention, described elsewhere.24,25 A baseline
household survey preceded the trial intervention; helminth‐allergy
associations at baseline have been reported.24 A household‐based
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allergy outcomes survey (the “rural survey”) was conducted between
September 2015 and August 2016, following 3 years of anthel-
minthic intervention: there was no difference in the prevalence of
allergy outcomes between the two trial arms.26 Sampling for the sur-
vey involved random selection of 70 households from each village
using a Stata program. All household members (1 year and older) of
selected households were then invited to participate. Permission for
household participation was granted by the household head.
The urban survey of allergy‐related outcomes (September 2016–
September 2017) was designed intentionally to collect data from
Entebbe municipality for comparison with the helminth‐endemic
rural survey. Before the start of the survey, each sub‐ward was
mapped onto satellite imagery of the municipality. A random point
generation function of ArcGIS software (version 10.4.1, Environmen-
tal Systems Research Institute, Redlands, CA) was then used to gen-
erate random starting points within each sub‐ward. The number of
starting points selected was proportional to the population size of
the sub‐ward. Coordinates of the random starting points generated
were loaded onto geographic information system (GIS) devices
(eTrex®, Garmin™ Ltd, Olathe, KS). These devices were then used in
the field to identify the selected random points, from which the
nearest four houses were surveyed.
There was no randomization to intensive or standard anthel-
minthic treatment in the urban survey; however, all other procedures
were designed to be identical in both the urban and the rural survey.
Following written informed consent and assent, questionnaires
were completed for each participant, capturing socio‐demographic,
clinical and behavioural characteristics as well as asthma, eczema
and allergy symptoms. The latter employed questions based on the
International Study on Allergy and Asthma in Children (ISAAC)
questionnaire. Blood, stool and mid‐stream urine were collected.
Blood samples were used for haemo‐parasitology, HIV serology and
storage of plasma and cells for immunoassays. One stool sample
per participant was examined for intestinal helminth infections
using the Kato‐Katz method27 (two slides, read by different tech-
nologists). The remaining sample was stored and later investigated
for Schistosoma mansoni (Sm), Strongyloides stercoralis and hook-
worm (Necator americanus) infections using multiplex real‐time
PCR.28,29 Urine was assessed for Sm circulating cathodic antigen
(CCA, Rapid Medical Diagnostics, Pretoria, South Africa). Schisto-
soma egg [SEA]‐ and adult worm [SWA] antigen‐specific
immunoglobulin (Ig)E, IgG4 and IgG levels were assessed in plasma
using in‐house ELISAs (Data S1).
Ethics committees of Uganda Virus Research Institute (refs: GC/
127/12/05/03 and GC/127/16/02/547) and London School of
Hygiene and Tropical Medicine, (refs: 6187 and 10709) and the
Uganda National Council for Science and Technology (ref: HS1183
and HS2036) approved both surveys.
2.2 | Allergy‐related outcomes
Outcomes were skin prick test (SPT) reactivity to allergens common
in our setting,30 allergen‐specific IgE (asIgE) sensitization, self‐
reported recent (previous 12 months) wheeze, recent rhinitis, recent
urticarial rash and visible flexural dermatitis.
Skin prick test reactivity (wheal ≥3 mm diameter after 15 min-
utes in the presence of saline [negative] and histamine [positive]
controls) to dust mites (Dermatophagoides mix, Blomia tropicalis) and
German cockroach (Blattella germanica) (ALK‐Abelló; supplied by
Laboratory Specialities [Pty] Ltd., Randburg, South Africa) was
F IGURE 1 Study flowchart
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assessed using standard procedures.31 SPT reactivity was defined
primarily as a positive response to any of the three allergens. SPT
reactivity was also analysed as a positive vs negative response to
individual allergens.
Whole allergen (Dermatophagoides pteronyssinus, peanut [A hy-
pogaea] and B germanica) extract‐specific plasma IgE (asIgE) was
measured by ImmunoCAP® (ThermoFisher Scientific, Uppsala, Swe-
den) in a sample of 780 and 345 rural and urban survey participants,
respectively, randomly selected from those with sufficient volume of
stored plasma. Allergen‐specific IgE sensitization was defined as a
positive ImmunoCAP response (IgE concentration ≥0.35kU/L) to any
of the three allergens and as a positive vs negative ImmunoCAP
response for individual allergens. ImmunoCAP IgE outcomes were
also analysed as continuous variables.
Wheeze is considered a good proxy for asthma in epidemiological
studies32 and was assessed separately in two age groups (≥5 years
and <5 years) using an interviewer‐administered ISAAC questionnaire.
The principal age group of interest was ≥5 years because wheeze can-
not be assumed to represent asthma in children below 5 years.33
Data on recent rhinitis (runny/blocked nose or sneezing accom-
panied by watery and itchy eyes, in the absence of cold or “flu”) and
urticarial rash (pruritic rash with weals, known as “ebilogologo” in
the local language [Luganda]) were obtained by questionnaire. Visible
flexural dermatitis was assessed (by staff trained on Williams’ online
manual34) as an erythematous rash with surface change in and
around skin creases.35,36
2.3 | Statistical methods
Data analysis was conducted using Stata 13.1 (College Station, TX).
The following were assessed as potential risk factors for allergy‐
related outcomes: socio‐demographic characteristics (age, sex, pres-
ence of older/younger siblings, maternal tribe, paternal tribe, location
of birth and occupation), behavioural characteristics (frequency of
lake contact, type of bathing water, handwashing behaviour, foot-
wear outside the house, smoking and alcohol use), clinical character-
istics (helminth infections, exposure to anthelminthic treatment in
utero, anthelminthic treatment in last 12 months, parental history of
allergies, BCG scar, immunisation history, malaria treatment in last
12 months, malaria infection and HIV infection) and immunological
characteristics (plasma SEA‐ and SWA‐specific IgE, IgG4 and IgG
levels). Additionally, allergy‐related outcomes were independently
assessed as risk factors for each other.
Stata “svy” commands were used to allow for clustering of par-
ticipants within villages and for the non‐self‐weighting design of the
rural survey24 and for clustering by sub‐ward in the urban survey.
Logistic regression was used to compare the prevalence of out-
comes and other characteristics between the rural and urban survey
and to assess associations between each pair of allergy‐related out-
comes in both surveys. Population attributable fractions (PAFs) for
pairs of allergy‐related outcomes were calculated. Interaction tests
were done to assess whether these associations differed by setting.
Unadjusted and adjusted odds ratios (OR) for associations between
exposures and allergy‐related outcomes were estimated using uni-
variable and multivariable logistic regression. Additionally, linear
regression was used in secondary analyses of ImmunoCAP IgE out-
comes as continuous variables. Age, sex (a priori) and factors show-
ing evidence of crude association with an outcome (P < 0.05) were
considered in multivariable analyses for that outcome. We hypothe-
sized that helminth infections might be key mediating factors on the
causal pathway between urban/rural residence and allergy‐related
outcomes; hence, helminths (and Sm-specific antibody responses and
other “helminth‐related” factors such as frequency of lake contact
and occupation) were not included in multivariable analyses for other
risk factors. The potential mediating role of helminths was then
investigated separately by assessing whether associations between
non‐helminth‐related risk factors and allergy‐related outcomes chan-
ged substantially when adjusted for Sm infections and Schistosoma‐
specific antibody levels. These analyses were initially conducted
separately for each survey. Subsequently, we merged data from the
two surveys and tested for interaction between the rural and urban
survey, to assess whether risk factors for allergy outcomes differed
by setting. Here, we also assessed the potential role of helminths in
urban‐rural interactions by comparing interaction P values before
and after adjusting for Sm infection. A 5% significance level was
used for all analyses.
3 | RESULTS
3.1 | Participants’ characteristics
Flowcharts of the surveys are shown in Figure 1. Of 1820 house-
holds randomly selected for the rural survey (70 from each of the 26
villages), 1419 (78%) took part. There were 3566 individuals inhabit-
ing the 1419 participating households; 3323 (93.2%) were inter-
viewed and 3346 (93.8%) had data on at least one allergy‐related
outcome. Of 420 households randomly selected for the urban sur-
vey, 416 (99%) took part. There were 1747 individuals inhabiting the
416 households; 1339 (77%) were interviewed and 1523 (87%) had
data on at least one allergy‐related outcome.
Participant characteristics differed between the two study set-
tings (Table 1). Significantly, rural, compared to urban participants,
were more likely to be infected with helminths (including Sm),
malaria and HIV, had higher median levels of Schistosoma‐specific
antibodies and were more likely to report anthelminthic or malaria
treatment in the previous 12 months. Dermatitis and SPT reactivity
were more prevalent among urban participants, while asIgE sensitiza-
tion and urticaria were more common among rural participants
(Table 1 and Figure 2A). The prevalence of wheeze and rhinitis was
similar between the two communities.
3.2 | Associations between allergy‐related
outcomes
Crude associations between allergy‐related outcomes are shown in
Table 2. Individuals who were ImmunoCAP asIgE sensitized were
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more likely to have a positive SPT response in both surveys; the
PAF for SPT reactivity associated with asIgE sensitization was 86.1%
and 80.9% for the urban and rural survey, respectively. Atopy mea-
sures (asIgE, SPT) were generally more strongly associated with
other allergy‐related conditions in the urban compared to rural
survey; asIgE‐rhinitis (interaction P = 0.081), asIgE‐urticaria (interac-
tion P = 0.056), SPT‐rhinitis (interaction P = 0.019) and SPT‐urticaria
(interaction P = 0.005) associations approached statistical signifi-
cance. Another major difference was that urticaria was associated
with wheeze, rhinitis and SPT reactivity in the urban survey, but not
with any allergy‐related outcome in the rural survey.
We hypothesized that helminth infection, particularly Sm infec-
tion, might mediate this effect modification between the urban and
rural setting (Figure 2B). However, the comparison of crude associa-
tions (reported above) with associations adjusted for current Sm
infection (generally, or categorized by infection intensity) and Schis-
tosoma‐specific antibody concentrations did not show clear differ-
ences in the test statistics (Table S1); hence, any mediating role of
current Sm infection, including effects on interactions between the
rural and urban survey, was not evident.
3.3 | Factors associated with skin prick test
reactivity
Table 3 and Table S2 show factors associated with SPT reactivity to
any of Dermatophagoides mix, B tropicalis or B germanica. In the urban
survey, increasing age, non‐Ugandan maternal tribe, being born in a
city (compared to town or village) and having a BCG scar were posi-
tively associated with SPT reactivity. Additionally, light Sm infection
(KK) and Sm infection (PCR) were positively associated with SPT reac-
tivity in the urban survey, in sharp contrast to observations in the rural
survey, where current Sm infection (KK, PCR and CCA) was associated
with reduced odds of SPT reactivity. This rural‐urban difference was
statistically significant (interaction P values = 0.002 and 0.015 for Sm‐
PCR and Sm‐KK intensity, respectively). Other factors inversely associ-
ated with SPT reactivity in the rural survey were related to helminth
infections and included bathing in lakewater and SWA‐specific IgG4.
In addition to the Sm‐SPT association, tests for interaction
showed that associations between several other risk factors and SPT
reactivity differed by survey setting. Being male (P = 0.015), mater-
nal history of allergies (P = 0.013), SWA‐specific IgG4 (P = 0.011)
and hand washing (P = 0.001) were positively associated with SPT in
the urban survey but inversely associated with the same outcome in
the rural survey. The inverse association between SPT and being
born in a village (compared to town or city) was stronger in the
urban compared to rural survey (P = 0.041).
Associations with SPT reactivity to individual allergens are sum-
marized in Table S3, and paint a similar picture.
Comparison of models with and without additional adjustment
for current Sm infection (generally, or categorized by infection inten-
sity) and Schistosoma‐specific antibodies did not suggest any mediat-
ing role of Sm infection in associations between non‐helminth‐
related risk factors and SPT reactivity, or in interactions between the
rural and urban survey (Table S4A).
3.4 | Factors associated with allergen‐specific IgE
sensitization
Table 4 and Table S5 show factors associated with ImmunoCAP IgE
sensitization to any of D pteronyssinus, A hypogaea or B germanica
extracts. In the urban survey, the presence of younger siblings and
SWA‐specific IgG were associated with asIgE sensitization. Rural par-
ticipants who washed hands after toilet use, slept under a mosquito
net and/or had recently been treated for malaria were less likely to
be asIgE sensitized. Engaging in agricultural/fishing/lake‐related activi-
ties or being unemployed, Sm infection (KK) and intensity, and ele-
vated SWA‐specific IgE increased the odds of asIgE sensitization.
The presence of younger siblings (interaction P = 0.008) and hand
washing (interaction P = 0.003) were associated with reduced odds of
asIgE sensitization in the rural but not the urban survey (Table 4). Adjust-
ing for Sm infection in multivariable analysis models did not suggest a
mediating role for Sm in these rural‐urban differences (Table S4B).
Table S6 summarizes factors associated with ImmunoCAP asIgE
sensitization to individual allergens: Schistosoma‐specific antibody
levels and helminth infections were the predominant risk factors in
both surveys. Hygiene practices (washing and bathing) reduced the
odds of sensitization in the rural but not urban survey.
3.5 | Factors associated with clinical allergy‐related
outcomes
Factors associated with self‐reported recent wheeze, urticarial rash
and rhinitis are shown in Table S7. Risk factors for visible flexural der-
matitis could not be assessed because it was rare in both settings. In
the urban survey, the presence of older siblings, handwashing before
eating, SWA‐specific IgG and SEA‐specific IgG were inversely associ-
ated with wheezing. In the rural survey, female sex and presence of
any nematode infection were inversely associated with wheezing,
while increasing age, SWA‐specific IgG, SEA‐specific IgG and paternal
history of allergies increased the odds of wheezing. Non‐Ugandan
paternal tribe (interaction P < 0.001) increased the odds of wheezing
in the urban but not rural survey, while SWA‐specific IgG (P < 0.001)
and SEA‐specific IgG (P = 0.001) were positively associated with
wheezing in the rural but not the urban survey.
Urban individuals who received any anthelminthic treatment in
the previous 12 months were more likely to report urticarial rash. In
the rural survey, increasing age, maternal history of allergies, SEA‐
specific IgE and recent malaria treatment were associated with urti-
caria. The association between SEA‐specific IgE and urticaria was
positive in the rural but not urban survey (interaction P = 0.022). No
other significant interactions were observed.
Maternal and paternal history of allergies, and HIV infection were
associated with rhinitis in the urban survey. The following were risk
factors for rhinitis in the rural survey: increasing age, presence of
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TABLE 1 Characteristics of study participants
Characteristics
Urban survey
n/N (%)a
Rural survey
n/N (%)a P value*
Socio‐demographic
Age in (y), median (IQR) 20 (8, 31) 24 (8, 34) 0.329**
Male sex 688/1610 (42.7) 1738/3350 (49.5) 0.002
Place of birth
City 53/513 (10.3) 61/2406 (2.9)
Town 138/513 (26.9) 254/2406 (10.4)
Village 322/513 (62.7) 2091/2406 (86.7) <0.001
Maternal tribe, larger region grouping
Central Uganda 605/1331 (45.5) 1197/3304 (36.5)
Other, Ugandan 607/1331 (45.6) 1588/3304 (48.1)
Non‐Ugandan, African 119/1331 (8.9) 519/3304 (15.4) 0.020
Paternal tribe, larger region grouping
Central Uganda 593/1334 (44.5) 1343/3317 (39.8)
Other, Ugandan 624/1334 (46.8) 1556/3317 (47.5)
Non‐Ugandan, African 117/1334 (8.7) 418/3317 (12.7) 0.208
Maternal history of allergies (general) 93/1187 (7.8) 366/2930 (12.7) <0.001
Paternal history of allergies (general) 30/1117 (2.6) 171/2796 (5.7) 0.005
Maternal history of asthma 27/1266 (2.1) 93/2931 (3.4) 0.167
Paternal history of asthma 27/1218 (2.2) 62/2796 (2.3) 0.950
Maternal history of eczema 35/1229 (2.8) 131/2931 (4.5) 0.206
Paternal history of eczema 15/1159 (1.3) 96/2795 (2.9) 0.028
Occupation, grouped by type
Student or child (not at school) 662/1338 (49.5) 1166/3323 (36.7)
Unemployed or housewife 292/1338 (21.8) 301/3323 (8.7)
Agricultural, fishing or lake related 60/1338 (4.5) 1389/3323 (38.8)
Professional or service providers
(Shops, saloons, bars, restaurants, entertainment)
324/1338 (24.2) 467/3323 (15.6) <0.001
Helminth infections
S mansoni (KK) 86/1197 (7.2) 846/2751 (31.8) <0.001
S mansoni intensity (KK)
Uninfected 1111/1197 (92.8) 1905/2751 (68.2)
Low 41/1197 (3.4) 425/2751 (15.7)
Moderate 31/1197 (2.6) 231/2751 (9.1)
Heavy 14/1197 (1.1) 190/2751 (7.1) <0.001
S mansoni (urine CCA) 581/1318 (44.1) 2445/2879 (85.6) <0.001
S mansoni (PCR) 204/1191 (17.1) 1338/2747 (50.0) <0.001
A lumbricoides (KK) 0/1197 (0.0) 14/2751 (0.4)
Trichuris trichiura (KK) 21/1196 (1.8) 245/2751 (7.8) <0.001
N americanus (PCR) 56/1191 (4.7) 259/2747 (8.4) 0.016
S stercoralis (PCR) 29/1191 (2.4) 190/2747 (6.2) <0.001
Schistosoma-specific antibody levels
SEA‐specific IgE (μg/mL), median (IQR) 2.7 (2.6, 2.8) 4.6 (4.3, 4.8) <0.001**
SWA‐specific IgE (μg/mL), median (IQR) 2.2 (2.1, 2.4) 4.9 (4.6, 5.1) <0.001**
SEA‐specific IgG4 (μg/mL), median (IQR) 30.8 (27.8, 37.3) 278.6 (228.7, 322.4) <0.001**
SWA‐specific IgG4 (μg/mL), median (IQR) 42.7 (40.5, 44.1) 108.6 (98.3, 124.7) <0.001**
(Continues)
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TABLE 1 (Continued)
Characteristics
Urban survey
n/N (%)a
Rural survey
n/N (%)a P value*
SEA‐specific IgG (μg/mL), median (IQR) 777.9 (744.6, 806.1) 1975.4 (1848.0, 2096.4) <0.001**
SWA‐specific IgG (μg/mL), median (IQR) 795.4 (771.2, 828.6) 1497.2 (1429.4, 1561.5) <0.001**
Allergy‐related outcomes
Skin prick test reactivity
Any 302/1317 (22.9) 576/3037 (19.1) 0.054
Dermatophagoides mix 228/1317 (17.3) 326/3037 (10.5) <0.001
B tropicalis 184/1317 (13.9) 229/3036 (7.9) <0.001
B germanica 186/1320 (14.1) 350/3035 (11.8) 0.137
Allergen‐specific IgE (≥0.35 kU/L, ImmunoCAP)
Any 148/345 (42.9) 437/780 (55.1) 0.007
D pteronyssinus 104/345 (30.1) 264/780 (33.2) 0.421
B germanica 118/345 (34.2) 393/780 (49.8) <0.001
A hypogaea 41/345 (11.8) 114/780 (14.9) 0.266
Total IgE (kU/L), median (IQR) 159 (56, 522) 672 (249, 1942) <0.001
Wheeze in last 12 mo, age<5 y 3/229 (1.3) 9/547 (1.4) 0.972
Wheeze in last 12 mo, age ≥ 5 y 24/1107 (2.2) 87/2776 (3.2) 0.190
Visible flexural dermatitis 22/1435 (1.5) 5/3111 (0.1) <0.001
Rhinitis in last 12 mo 45/1336 (3.4) 104/3323 (3.2) 0.806
Urticarial rash in last 12 mo 53/1336 (3.9) 334/3322 (9.9) <0.001
Other
Any worm treatment in the last 12 mo 795/1296 (61.3) 2938/3307 (87.7) <0.001
Malaria treatment in the last 12 mos 506/1336 (37.8) 1993/3323 (60.8) <0.001
P falciparum positivity by blood smear 3/1347 (0.2) 102/2923 (3.7) <0.001
HIV infection 66/1339 (4.9) 402/2399 (17.3) <0.001
CCA: circulating cathodic antigen; IQR: interquartile range; KK: Kato‐Katz; PCR: polymerase chain reaction; SEA: Schistosoma egg antigen; SWA: Schis-
tosoma adult worm antigen.
aPercentages adjusted for survey design. Percentages that are significantly higher in one setting compared to the other (P ≤ 0.05) are highlighted in
bold. Adjusting for age and sex differences had no significant impact on these differences.
*P values obtained from survey design‐based logistic regression.
**P values obtained from survey design‐based linear regression.
F IGURE 2 Urban‐rural differences in risk factors for allergy‐related outcomes in Uganda: a role for helminths? A, summary of principal
findings regarding prevalence of allergy‐related outcomes in urban Uganda and in rural Ugandan fishing communities. B, Risk factors for
allergy‐related outcomes differed between urban and rural settings. Our data suggest that helminth exposure is unlikely to be the only factor
involved in this effect modification. Additional hypothesized effect modifiers are indicated
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older siblings, being born in a city (compared to town or village) and
bathing in lakewater. The positive association between HIV and
rhinitis was stronger in the urban compared to the rural survey (in-
teraction P = 0.028). No other significant interactions were
observed.
We did not find any evidence to suggest that current Sm infec-
tion influenced associations between non‐helminth‐related risk fac-
tors and clinical allergy‐related outcomes, and interactions between
the rural and urban survey (Table S4, C-E).
4 | DISCUSSION
We show risk factors for allergy‐related outcomes in proximate
Ugandan rural and urban settings. The rural setting was
characterized by a significantly higher prevalence of Sm and nema-
tode infections compared to the urban setting. The prevalence of
SPT reactivity and visible flexural dermatitis was lower, and that of
asIgE sensitization and urticaria higher, in the rural compared to
urban setting. Risk factors for these outcomes differed by setting.
We investigated the hypothesis that rural‐urban differences in risk
factors for allergy were attributable to differences in current Sm
exposure. Despite observations that the rural environment (and
higher intensity Sm infection within it) was associated with reduced
odds of SPT reactivity, statistical analyses did not confirm a mediat-
ing role for current Sm infection in the rural‐urban differences, imply-
ing that other exposures may play important roles. Similarly, rural‐
urban differences in associations with clinical allergy outcomes could
not categorically be attributed to differences in current Sm infection
between the two settings.
TABLE 2 Crude associations between allergy‐related outcomes
SPT Wheeze Rhinitis Urticaria
asIgE
Urban OR (95% CI) 21.4 (10.2, 44.6) 5.5 (0.4, 68.6) 3.7 (1.2, 11.9) 3.7 (0.8, 16.2)
P value <0.001 0.171 0.028 0.075
PAF (95% CI) 86.1% (81.4, 88.3) 65.5% (−120, 78.8) 53.1% (12.1, 66.6) 53.1% (−18.2, 68.2)
Rural OR (95% CI) 10.3 (5.3, 19.8) 3.9 (1.3, 11.5) 1.1 (0.5, 2.6) 0.9 (0.6, 1.3)
P value <0.001 0.015 0.793 0.651
PAF (95% CI) 80.9% (72.7, 85.1) 62.2% (19.3, 76.5) 5.7% (−57.9, 35.6) −4.7% (−35.8, 12.4)
Interaction P value 0.127 0.792 0.081 0.056
SPT
Urban OR (95% CI) 2.2 (0.6, 8.1) 6.5 (3.4, 12.5) 2.2 (1.6, 2.8)
P value 0.211 <0.001 <0.001
PAF (95% CI) 23.4% (−28.6, 37.6) 54.2% (45.2, 58.9) 20.8% (14.4, 24.6)
Rural OR (95% CI) 3.0 (1.8, 5.1) 2.6 (1.7, 3.9) 1.2 (0.9, 1.6)
P value <0.001 <0.001 0.243
PAF (95% CI) 29.2% (17.6, 31.9) 23.4% (15.5, 27.9) 3.6% (−2.4, 20.9)
Interaction P value 0.647 0.019 0.005
Wheeze
Urban OR (95% CI) 7.4 (1.7, 33.2) 4.9 (1.1, 21.7)
P value 0.011 0.035
Rural OR (95% CI) 11.9 (5.7, 24.9) 1.4 (0.6, 3.3)
P value <0.001 0.403
Interaction P value 0.557 0.127
Rhinitis
Urban OR (95% CI) 9.6 (5.6, 16.4)
P value <0.001
Rural OR (95% CI) 0.7 (0.3, 1.6)
P value 0.429
Interaction P value <0.001
asIgE: ImmunoCAP IgE sensitization to any of D pteronyssinus, A hypogaea, or B germanica on ImmunoCAP; SPT: skin prick test reactivity to any of Der-
matophagoides mix, B tropicalis or B germanica.
Odds ratios (ORs), P values and population attributable fractions (PAFs) were obtained from survey design‐adjusted analyses. Visible flexural dermatitis
was not assessed because it was rare. Significant associations are highlighted in bold. Interaction P values are shown to denote whether tests for inter-
action showed statistical evidence for urban‐rural differences in associations between allergy‐related outcomes, or not.
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TABLE 3 Factors associated with SPT reactivity to any of Dermatophagoides mix, B tropicalis or B germanica
Factor
Urban Rural
Interaction PN (%)a aOR (95% CI)bc P N (%)a aOR (95% CI)bd P
Age 1.02 (1.00, 1.03) 0.035 1.02 (1.00, 1.03) 0.015 0.384
Sex
Male 132 (26) 1 285 (18) 1
Female 170 (21) 0.71 (0.49, 1.02) 0.061 291 (20) 1.09 (0.79, 1.52) 0.558 0.015
Older siblings (Yes/No)
No 73 (22) 1 113 (24) 1
Yes 194 (23) 1.58 (0.90, 2.76) 0.103 341 (22) 0.76 (0.56, 1.03) 0.076 0.133
Occupation
Student or child (not at school) 111 (20) 1 136 (13) 1
Unemployed or housewife 63 (24) 1.21 (0.70, 2.08) 61 (22) 0.79 (0.34, 1.85)
Agricultural, fishing or lake related 11 (20) 0.74 (0.29, 1.87) 273 (22) 0.83 (0.39, 1.72)
Professional or service providers 82 (28) 1.26 (0.77, 2.06) 0.709 103 (25) 0.93 (0.54, 1.62) 0.932 0.473
Maternal tribe
Central Uganda 127 (25) 1 212 (20) 1
Other, Ugandan 113 (21) 0.82 (0.52, 1.30) 272 (19) 0.86 (0.59, 1.27)
Non‐Ugandan, African 26 (25) 1.77 (1.17, 2.70) 0.015 86 (18) 0.76 (0.44, 1.32) 0.613 0.127
Maternal history of allergies
No 192 (21) 1 433 (20) 1
Yes 34 (31) 1.68 (0.89, 3.18) 0.107 71 (15) 0.90 (0.58, 1.41) 0.644 0.013
Location of birth
City 16 (37) 1 12 (21) 1
Town 34 (28) 0.56 (0.30, 1.02) 57 (24) 0.75 (0.37, 1.52)
Village 60 (21) 0.34 (0.18, 0.61) 0.004 397 (21) 0.61 (0.29, 1.28) 0.419 0.041
BCG scar
No 67 (19) 1 228 (19) 1
Yes 234 (24) 2.22 (1.24, 3.97) 0.010 345 (19) 1.31 (0.96, 1.79) 0.083 0.601
Lake contact
Never 72 (18) 1
Rarely 140 (27) 0.92 (0.50, 1.67) 22 (33) 1
Once a month 29 (24) 0.78 (0.39, 1.61)
Once a week 26 (23) 1.04 (0.42, 2.57) 0.896 47 (24) 1.04 (0.64, 1.68)
Daily/almost daily 385 (22) 0.89 (0.54, 1.48) 0.499
Bathe in water from lake?
No 249 (23) 1 25 (36) 1
Yes 18 (18) 0.75 (0.27, 2.06) 0.558 429 (22) 0.41 (0.24, 0.71) 0.002 0.172
Hand washing after toilet
No 19 (12) 1 151 (23) 1
Yes 248 (25) 4.67 (0.88, 24.8) 0.068 303 (22) 0.78 (0.59, 1.02) 0.068 0.001
SWA‐specific IgG4e 1.04 (0.86, 1.24) 0.691 0.77 (0.63, 0.94) 0.013 0.011
SEA‐specific IgEe 1.32 (0.90, 1.91) 0.135 0.58 (0.29, 1.16) 0.119 0.109
Sm infection (KK)
Uninfected 221 (22) 1 376 (21) 1
Infected 20 (26) 1.47 (0.76, 2.83) 0.239 127 (16) 0.68 (0.47, 0.97) 0.038 0.332
Sm infection intensity (KK)
Uninfected 221 (22) 1 376 (21) 1
(Continues)
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Our rural and urban settings were atypical. Observations in the
rural survey are against a backdrop of three years of well‐organized
community‐level anthelminthic intervention25 that led to a decline in
helminth intensity in both standard and intensive treatment arms,
but had no effect on overall Sm prevalence.26 Before analysis of risk
factors, we confirmed a lack of effect of the intensive (compared
with standard) anthelminthic treatment on allergy‐related outcomes.
The urban survey was done in the unusual context of a setting with
considerable exposure to light Sm infection (inferred from 44% urine
CCA positivity). However, this enabled us to adjust for Sm infection
in both settings and hence explore the role of Sm in interactions
between the settings. Recruitment of participants in the urban sur-
vey was done after conclusion of the rural survey; however, this is
unlikely to account for observed urban‐rural differences in allergy
risk factors, as both surveys were conducted by the same research
team, and covered approximately 1 year (so any seasonal effects
were approximately matched). Another potential limitation was the
large number of statistical tests, increasing likelihood of chance find-
ings. However, we were cautious to look for patterns of association
rather than interpreting individual results equally.
In keeping with the “old friends” hypothesis1 and observations
from several studies,37-39 SPT reactivity was less prevalent in the
helminth‐endemic rural setting and was inversely associated with
helminth infections in the same setting. The only exception was Tri-
churis trichiura infection, which was weakly positively associated with
Dermatophagoides SPT (Table S3). This lone observation was also
manifest in the same communities in a baseline household survey
3 years earlier,24 although no other helminth species were associated
with SPT then. The current observations beg further investigation
into the impact of anthelminthic treatment on SPT‐helminth associa-
tions in a helminth‐endemic setting. In mice, allergic airway inflam-
mation is increased during acute Sm infection but reduces drastically
with progression to chronic infection.40 In our urban setting, light Sm
infection was positively associated with SPT reactivity while moder-
ate and heavy infections were inversely associated with the same
outcome (Table 3). “Helminth‐related” behavioural characteristics
were also inversely associated with SPT reactivity in the rural survey.
It is plausible that in these fishing communities, frequent lake con-
tact, bathing in lakewater and handwashing, for example, increase
the risk for Sm infection through contact with infected snails. Indeed,
these characteristics were strongly associated with Sm infection
(P < 0.001). However, the same characteristics were also inversely
associated with asIgE sensitization in the rural survey but not in the
urban survey.
As discussed earlier, Pinot de Moira and colleagues’ study in a
Ugandan village found that hookworm infection abrogated the
TABLE 3 (Continued)
Factor
Urban Rural
Interaction PN (%)a aOR (95% CI)bc P N (%)a aOR (95% CI)bd P
Light 15 (38) 2.39 (1.24, 4.64) 65 (16) 0.66 (0.43, 1.01)
Moderate 3 (12) 0.76 (0.22, 2.61) 40 (18) 0.83 (0.52, 1.34)
Heavy 2 (14) 0.55 (0.05, 6.81) 0.055 22 (12) 0.49 (0.22, 1.14) 0.053 0.015
Sm infection (PCR)
Uninfected 188 (21) 1 289 (22) 1
Infected 48 (25) 1.57 (1.01, 2.43) 0.044 214 (17) 0.66 (0.49, 0.89) 0.010 0.002
Sm infection (CCA)
Negative 163 (24) 1 114 (27) 1
Positive 115 (22) 1.19 (0.69, 2.06) 0.517 414 (18) 0.56 (0.37, 0.83) 0.006 0.184
Malaria treatment, last 12 mo
No 163 (24) 1 234 (21) 1
Yes 100 (22) 0.86 (0.52, 1.42) 0.536 323 (18) 1.08 (0.85, 1.38) 0.502 0.730
HIV
Negative 272 (22) 1 380 (19) 1
Positive 19 (32) 1.82 (0.56, 5.93) 0.302 98 (25) 1.17 (0.74, 1.85) 0.495 0.440
Associations shown in this table are from adjusted analyses. Full table with crude associations is shown in supplementary Table S1. This table shows
only factors that were associated with SPT reactivity (before and/or after adjustment) in either the urban or the rural survey. All other factors that were
assessed are listed in the statistical methods section. Significant associations are highlighted in bold. Interaction P values are shown to establish whether
associations between potential risk factors and SPT reactivity differed, or not, given the setting.
aOR: adjusted odds ratios; CCA: circulating cathodic antigen; KK: Kato‐Katz; PCR: Polymerase Chain Reaction; SEA: Schistosoma egg antigen; SWA:
Schistosoma adult worm antigen.
aNumber (percentage in parenthesis) of SPT reactive individuals in each category.
bOdds ratios (ORs) and 95% confidence intervals (CI) were adjusted for survey design.
cORs were adjusted for location of birth, BCG scar, hand washing after toilet use, alcohol use, age and sex.
dORs were adjusted for HIV infection status, maternal history of allergies, recent malaria treatment, presence/absence of older siblings, age and sex.
eLog10 (concentration+1) transformation applied before analysis.
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predicted association between Dermatophagoides‐specific IgE and
basophil histamine release.22 We postulated that the rural setting
might interfere with the link between atopic sensitization (asIgE,
SPT) and clinical outcomes (reported wheeze and rhinitis) through
high helminth exposure. Indeed, we found that associations
between asIgE or SPT sensitization and clinical outcomes were
weak among participants from the rural compared to the urban
setting. However, statistical analyses did not suggest that this
TABLE 4 Factors associated with IgE sensitization (ImmunoCAP IgE > 0.35 kU/L) to any of D pteronyssinus, A hypogaea or B germanica
Factor
Urban Rural
Interaction PN (%)a aOR (95% CI)bd P N (%)a aOR (95% CI)bc P
Age 0.99 (0.98, 1.01) 0.547 1.01 (0.98, 1.03) 0.589 0.728
Sex
Male 47 (48) 1 241 (64) 1
Female 101 (41) 0.77 (0.51, 1.15) 0.200 196 (49) 0.69 (0.42, 1.14) 0.140 0.407
Younger siblings (Yes/No)
No 27 (33) 1 61 (62) 1
Yes 106 (46) 2.07 (1.07, 4.01) 0.030 313 (56) 0.76 (0.53, 1.09) 0.129 0.008
Occupation
Student or child (not at school) 68 (48) 1 64 (51) 1
Unemployed or housewife 34 (40) 0.70 (0.31, 1.60) 58 (54) 2.05 (1.38, 3.03)
Agricultural, fishing or lake related 4 (36) 0.56 (0.13, 2.46) 251 (61) 1.87 (1.04, 3.37)
Professional or service providers 27 (38) 0.61 (0.26, 1.43) 0.725 61 (47) 1.38 (0.72, 2.66) 0.014 0.148
Lake contact
Never 39 (45) 1
Rarely 69 (42) 0.98 (0.52, 1.85) 8 (42) 1
Once a month 11 (35) 0.74 (0.38, 1.41)
Once a week 14 (50) 1.32 (0.49, 3.55) 0.835 25 (44) 0.82 (0.23, 2.89)
Daily/almost daily 343 (59) 1.64 (0.45, 5.90) 0.174
Bathe in water from lake?
No 121 (42) 1 15 (63) 1
Yes 12 (57) 1.86 (0.50, 6.87) 0.331 361 (57) 0.42 (0.15, 1.11) 0.078 0.065
Hand washing after toilet
No 15 (39) 1 148 (71) 1
Yes 117 (43) 1.36 (0.69, 2.66) 0.344 228 (50) 0.43 (0.30, 0.61) <0.001 0.003
SWA‐specific IgEe 2.95 (0.51, 17.2) 0.214 6.17 (2.79, 13.6) <0.001 0.459
SWA‐specific IgG4e 1.01 (0.85, 1.19) 0.932 1.07 (0.89, 1.27) 0.470 0.433
SEA‐specific IgG4e 1.11 (0.97, 1.25) 0.102 1.07 (0.95, 1.21) 0.227 0.704
SWA‐specific IgGe 3.33 (1.12, 9.86) 0.031 1.53 (0.82, 2.86) 0.177 0.340
SEA‐specific IgGe 1.77 (0.63, 4.96) 0.260 1.43 (0.88, 2.30) 0.138 0.796
S mansoni infection (KK)
Uninfected 119 (44) 1 271 (55) 1
Infected 6 (43) 1.06 (0.34, 3.35) 0.910 118 (63) 1.52 (1.19, 1.94) 0.002 0.180
S mansoni infection intensity (KK)
Uninfected 119 (44) 1 271 (55) 1
Light 2 (29) 0.66 (0.11, 4.04) 54 (57) 1.74 (1.18, 2.54)
Moderate 2 (50) 1.20 (0.16, 8.79) 35 (66) 0.94 (0.46, 1.90)
Heavy 2 (67) 2.32 (0.13, 40.9) 0.662 29 (73) 2.37 (0.71, 7.83) 0.028 0.536
Any nematode infectionf
No 109 (42) 1 281 (54) 1
Yes 16 (62) 2.34 (0.76, 7.19) 0.130 108 (66) 1.53 (0.94, 2.49) 0.084 0.287
(Continues)
NKURUNUNGI ET AL. | 11
difference was mediated by current Sm infection. Furthermore, the
PAF for SPT associated with asIgE in both the helminth‐endemic
rural survey and in the urban survey was high, and adjusting for
Sm or Schistosoma‐specific antibodies had no effect on this
association.
Allergen‐specific IgE sensitization, particularly to cockroach, was
more prevalent in the rural compared to the urban setting, possibly
due to the higher helminth prevalence in the former. Additionally,
helminth infections and Schistosoma‐specific antibody levels were
positively associated with asIgE in both surveys. Our immunoassays
measured IgE sensitization to crude allergen extracts; these may con-
tain cross‐reactive components that are conserved in several hel-
minth antigens,41-46 explaining the above associations. These cross‐
reactive components may be less effective at mediating the effector
phase of the allergic response, explaining the lower prevalence of
SPT reactivity in the helminth‐endemic rural survey.
Associations with wheeze and rhinitis should be interpreted with
caution, because these outcomes were relatively rare. Furthermore,
reported wheeze can easily be misclassified in these populations,
because there is no direct translation of the word “wheeze” in the
local languages.24,47 Nonetheless, rural‐urban differences in the risk
factors for these outcomes were visible. For example, while Schisto-
soma‐specific antibody levels were inversely associated with wheez-
ing in the urban survey, the reverse was true in the rural setting.
Urticarial rash was a more common outcome, particularly in the hel-
minth‐endemic rural survey, where it may be indicative of parasite‐
induced skin allergy48 and reaction to parasite antigens following
anthelminthic treatment.49 Support for these deductions comes from
our observations that recent anthelminthic treatment (urban survey)
and SEA‐specific IgE (rural survey) were associated with urticaria.
In conclusion, we show that risk factors for allergy‐related out-
comes differ between rural and urban communities in this tropical
setting. However, our analyses did not confirm a role for current
helminth (Sm) infection as the primary mechanism of the observed
effect modification between the two settings, despite indicative
trends. Differences in other environmental exposures may contribute
significantly.
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TABLE 4 (Continued)
Factor
Urban Rural
Interaction PN (%)a aOR (95% CI)bd P N (%)a aOR (95% CI)bc P
Slept under mosquito net last night?
No 35 (45) 1 203 (62) 1
Yes 97 (42) 0.93 (0.52, 1.66) 0.958 172 (52) 0.63 (0.41, 0.97) 0.037 0.316
Malaria treatment, last 12 mo
No 83 (45) 1 202 (63) 1
Yes 48 (39) 0.78 (0.46, 1.35) 0.365 221 (51) 0.52 (0.34, 0.81) 0.005 0.185
Associations shown in this table are from adjusted analyses. Full table with crude associations is shown in supplementary Table S1. This table shows
only factors that were associated with IgE sensitization (before and/or after adjustment) in either the urban or the rural survey. All other factors that
were assessed are listed in the statistical methods section. Significant associations are highlighted in bold. Interaction P values are shown to denote
whether tests for interaction showed statistical evidence for urban‐rural differences in associations with IgE sensitization, or not.
aOR: adjusted odds ratios; KK: Kato‐Katz; SWA: Schistosoma adult worm antigen; SEA: Schistosoma egg antigen.
aNumber (percentage in parenthesis) of IgE sensitized individuals in each category.
bOdds ratios (ORs) and 95% confidence intervals (CI) adjusted for survey design.
cAll ORs were adjusted for hand washing after toilet use, mosquito net use, malaria treatment, age and sex.
dAll ORs were adjusted for age and sex.
eLog10 (concentration+1) transformation applied before analysis.
fInfection with any of Ascaris lumbricoides, Trichuris trichiura (assessed by KK), Necator americanus, Strongyloides stercoralis (assessed by PCR).
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